Glass in Generic Lipitor Halts Production

Written By Unknown on Saturday, 1 December 2012 | 02:53

PHOTO: The Federal Drug Administration overnight pronounced Ranbaxy has concluded to stop production Atorvastatin, a general chronicle of Lipitor.

Ranbaxy Pharmaceuticals Inc., a association that creates a general chronicle of a cholesterol-controlling medicine Lipitor, has concluded to stop producing a drug since it is incompetent to explain because some of a tablets are laced with little pieces of glass.

Millions of Americans take Lipitor and the general versions to control their

Read full article: http://www.telegraph.co.uk/news/worldnews/middleeast/syria/9709946/West-could-arm-Syrian-rebels-within-months-after-Britain-wins-diplomatic-battle.html


Source:
http://www.news.ezonearticle.com/2012/12/01/glass-in-generic-lipitor-halts-production/

0 comments:

Post a Comment